Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
Melissa M. Phillips, Michael T. Sheaff, Peter W. Szlosarek
Cancer Res Treat. 2013;45(4):251-262.   Published online 2013 Dec 31     DOI: https://doi.org/10.4143/crt.2013.45.4.251
Citations to this article as recorded by Crossref logo
Nano-medicine therapy reprogramming metabolic network of tumor microenvironment: new opportunity for cancer therapies
Xiaojie Zhang, Min An, Juntao Zhang, Yumeng Zhao, Yanhua Liu
Journal of Drug Targeting.2024; : 1.     CrossRef
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Hamed M. El-Shora, Nessma A. El-Zawawy, Mohamed A. Abd El-Rheem, Metwally A. Metwally
BMC Microbiology.2024;[Epub]     CrossRef
L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction
Amany A. Hassabo, Mohamed Abdelraof, Rasha M. Allam
International Journal of Biological Macromolecules.2023; 224: 634.     CrossRef
Arginine transportation mechanism through cationic amino acid transporter 1: insights from molecular dynamics studies
Maral Afshinpour, Hamid Mahdiuni
Journal of Biomolecular Structure and Dynamics.2023; 41(23): 13580.     CrossRef
Autophagy and autophagy-related pathways in cancer
Jayanta Debnath, Noor Gammoh, Kevin M. Ryan
Nature Reviews Molecular Cell Biology.2023; 24(8): 560.     CrossRef
Amino acids in hematologic malignancies: Current status and future perspective
Mengyao Wang, Ailin Zhao, Meng Li, Ting Niu
Frontiers in Nutrition.2023;[Epub]     CrossRef
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
Melissa M. Phillips, Iuliia Pavlyk, Michael Allen, Essam Ghazaly, Rosalind Cutts, Josephine Carpentier, Joe Scott Berry, Callum Nattress, Shenghui Feng, Gunnel Hallden, Claude Chelala, John Bomalaski, Jeremy Steele, Michael Sheaff, Frances Balkwill, Peter
Pharmacological Reports.2023; 75(3): 570.     CrossRef
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tataru, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno, Giuseppe Lucarelli
Biomedicines.2023; 11(4): 1071.     CrossRef
Enzyme Cascade with Horseradish Peroxidase Readout for High-Throughput Screening and Engineering of Human Arginase-1
Jaime Fernández De Santaella, Jin Ren, Rosario Vanella, Michael A. Nash
Analytical Chemistry.2023; 95(18): 7150.     CrossRef
Human arginase I: a potential broad-spectrum anti-cancer agent
J. Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H. Pande
3 Biotech.2023;[Epub]     CrossRef
Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
Federica Borea, Marika A. Franczak, Maria Garcia, Matteo Perrino, Nadia Cordua, Ryszard T. Smolenski, Godefridus J. Peters, Rafal Dziadziuszko, Armando Santoro, Paolo A. Zucali, Elisa Giovannetti
International Journal of Molecular Sciences.2023; 24(11): 9165.     CrossRef
Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy
Ángela Marrugal, Irene Ferrer, Álvaro Quintanal-Villalonga, Laura Ojeda, María Dolores Pastor, Ricardo García-Luján, Amancio Carnero, Luis Paz-Ares, Sonia Molina-Pinelo
International Journal of Molecular Sciences.2023; 24(18): 13830.     CrossRef
Chronic Stress Blocks the Endometriosis Immune Response by Metabolic Reprogramming
Chong Lu, Jing Xu, Ke Li, Jing Wang, Yilin Dai, Yiqing Chen, Ranran Chai, Congjian Xu, Yu Kang
International Journal of Molecular Sciences.2023; 25(1): 29.     CrossRef
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, Xiao Zhang, Tao Xi, Shengtao Yuan, Haiping Hao, Jing Xiong
Acta Pharmaceutica Sinica B.2022; 12(2): 558.     CrossRef
The effect of l-arginine supplementation and surgical trauma on the frequency of myeloid-derived suppressor cells and T lymphocytes in tumour and blood of colorectal cancer patients
Jarosław Szefel, Tomasz Ślebioda, Jakub Walczak, Wiesław Janusz Kruszewski, Mariusz Szajewski, Maciej Ciesielski, Marcin Stanisławowski, Tomasz Buczek, Sylwia Małgorzewicz, Anna Owczarzak, Ewa Aleksandrowicz-Wrona, Grzegorz Krzykowski
Advances in Medical Sciences.2022; 67(1): 66.     CrossRef
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim, Helena Kupcova Skalnikova, Jana Cizkova, Veronika Cizkova, Anna Palanova, Vratislav Horak, Jakub Mrazek
BMC Microbiology.2022;[Epub]     CrossRef
Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming
Muhua Chen, Chunfeng Zhang, Wei Liu, Xiaojuan Du, Xiaofeng Liu, Baocai Xing
Molecular Therapy.2022; 30(6): 2354.     CrossRef
Liver-resident memory T cells: life in lockdown
Laura J. Pallett, Mala K. Maini
Seminars in Immunopathology.2022; 44(6): 813.     CrossRef
Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
Xiaoshuang Hou, Sui Chen, Po Zhang, Dongsheng Guo, Baofeng Wang
Frontiers in Oncology.2022;[Epub]     CrossRef
A virulence factor as a therapeutic: the probiotic Enterococcus faecium SF68 arginine deiminase inhibits innate immune signaling pathways
Fereshteh Ghazisaeedi, Jochen Meens, Bianca Hansche, Sven Maurischat, Peter Schwerk, Ralph Goethe, Lothar H. Wieler, Marcus Fulde, Karsten Tedin
Gut Microbes.2022;[Epub]     CrossRef
Cell metabolomics study on synergistic anti‐hepatocellular carcinoma effect of Aidi injection combined with doxorubicin
Yanli Wang, Xiaoqing Zhu, Kailiang Wang, Ying Cai, Chunhua Liu, Jie Pan, Jia Sun, Ting Liu, Yong Huang, Yongjun Li, Yuan Lu
Biomedical Chromatography.2022;[Epub]     CrossRef
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts
Dong Hang, Xiaolin Yang, JiaYi Lu, Chong Shen, Juncheng Dai, Xiangfeng Lu, Guangfu Jin, Zhibin Hu, Dongfeng Gu, Hongxia Ma, Hongbing Shen
International Journal of Cancer.2022; 151(12): 2144.     CrossRef
Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase
Teresa A. Szyszko, Joel T. Dunn, Melissa M. Phillips, John Bomalaski, Michael T. Sheaff, Steve Ellis, Lucy Pike, Vicky Goh, Gary J.R. Cook, Peter W. Szlosarek
JTO Clinical and Research Reports.2022; 3(9): 100382.     CrossRef
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
Joséphine Carpentier, Iuliia Pavlyk, Uma Mukherjee, Peter E Hall, Peter W Szlosarek
Lung Cancer: Targets and Therapy.2022; Volume 13: 53.     CrossRef
Human arginase 1, a Jack of all trades?
J. Anakha, Priyanka S. Kawathe, Sayantap Datta, Snehal Sainath Jawalekar, Uttam Chand Banerjee, Abhay H. Pande
3 Biotech.2022;[Epub]     CrossRef
Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy
Remya Nair, Pulkit Gupta, Mala Shanmugam
Frontiers in Oncology.2022;[Epub]     CrossRef
Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein
Haein Lee, Geunhwa Park, Seulha Kim, Boram Son, Jinmyoung Joo, Hee Ho Park, Tai Hyun Park
Applied Microbiology and Biotechnology.2022; 106(22): 7531.     CrossRef
Cationic amino acid transporter-1 (CAT-1) promotes fibroblast-like synoviocyte proliferation and cytokine secretion by taking up L-arginine in rheumatoid arthritis
Ying Lu, Chongbo Hao, Shanshan Yu, Zuan Ma, Xuelian Fu, Mingqing Qin, Menglei Ding, Zengguang Xu, Lieying Fan
Arthritis Research & Therapy.2022;[Epub]     CrossRef
Research progress in inducing immunogenic cell death of tumor cells
Deqian Xie, Qifei Wang, Guangzhen Wu
Frontiers in Immunology.2022;[Epub]     CrossRef
Unbalanced Glutamine Partitioning between CD8T Cells and Cancer Cells Accompanied by Immune Cell Dysfunction in Hepatocellular Carcinoma
Jianfei Chen, Rui Wang, Zhongliang Liu, Jun Fan, Shenglu Liu, Shunde Tan, Xinkai Li, Bo Li, Xiaoli Yang
Cells.2022; 11(23): 3924.     CrossRef
Plasma amino acids indicate glioblastoma with ATRX loss
Ernest Jan Bobeff, Dorota Szczesna, Michał Bieńkowski, Karolina Janczar, Malgorzata Chmielewska-Kassassir, Karol Wiśniewski, Wielisław Papierz, Lucyna Alicja Wozniak, Dariusz Jan Jaskólski
Amino Acids.2021; 53(1): 119.     CrossRef
Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment
Kuo-Ming Yu, Tammy Pui-shi Pang, Murray Cutler, Min Tian, Lynn Huang, Johnson Yiu-Nam Lau, Sai-Fung Chung, Thomas Wai-hung Lo, Thomas Yun-chung Leung
Life Sciences.2021; 264: 118674.     CrossRef
Dietary intervention as a therapeutic for cancer
Mami Morita, Kei Kudo, Hiroshi Shima, Nobuhiro Tanuma
Cancer Science.2021; 112(2): 498.     CrossRef
Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers
Gaurav Pathria, Ze’ev A. Ronai
Cell Metabolism.2021; 33(1): 9.     CrossRef
Pegylated arginine deiminase depletes plasma arginine but maintains tissue arginine availability in young pigs
Mahmoud A. Mohammad, Inka C. Didelija, Barbara Stoll, Trung C. Nguyen, Juan C. Marini
American Journal of Physiology-Endocrinology and Metabolism.2021; 320(3): E641.     CrossRef
Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy
Macus Kuo, Helen Chen, Lynn Feun, Niramol Savaraj
Pharmaceuticals.2021; 14(1): 72.     CrossRef
Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy
Mylène Tajan, Marc Hennequart, Eric C. Cheung, Fabio Zani, Andreas K. Hock, Nathalie Legrave, Oliver D. K. Maddocks, Rachel A. Ridgway, Dimitris Athineos, Alejandro Suárez-Bonnet, Robert L. Ludwig, Laura Novellasdemunt, Nikolaos Angelis, Vivian S. W. Li,
Nature Communications.2021;[Epub]     CrossRef
Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro
Zhiying Huang, Haifeng Hu
Molecules.2021; 26(2): 511.     CrossRef
The cancer metabolic reprogramming and immune response
Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Yaqian Han, Nayiyuan Wu, Pin Yi, Lu Tang, Qing Pan, Shan Rao, Jiaxin Liang, Yanyan Tang, Min Su, Xia Luo, Yiqing Yang, Yingrui Shi, Hui Wang, Yujuan Zhou, Qianjin Liao
Molecular Cancer.2021;[Epub]     CrossRef
Metabolomic characterisation of progression and spontaneous regression of melanoma in the melanoma-bearing Libechov minipig model
Martin Kertys, Marian Grendar, Vratislav Horak, Nela Zidekova, Helena Kupcova Skalnikova, Juraj Mokry, Erika Halasova, Jan Strnadel
Melanoma Research.2021; 31(2): 140.     CrossRef
Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia
Hui‐Jen Tsai, Hui‐Hua Hsiao, Ya‐Ting Hsu, Yi‐Chang Liu, Hsiao‐Wen Kao, Ta‐Chih Liu, Shih‐Feng Cho, Xiaoxing Feng, Amanda Johnston, John S. Bomalaski, Ming‐Chung Kuo, Tsai‐Yun Chen
Cancer Medicine.2021; 10(9): 2946.     CrossRef
Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Mark D. Badeaux, Annah S. Rolig, Giulia Agnello, Danlee Enzler, Melissa J. Kasiewicz, Leslie Priddy, Jason F. Wiggins, Alexander Muir, Mark R. Sullivan, Jessica Van Cleef, Christopher Daige, Matthew G. Vander Heiden, Venkatesh Rajamanickam, James E. Woold
Cancer Immunology Research.2021; 9(4): 415.     CrossRef
Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
Zizheng Zou, Xiyuan Hu, Tiao Luo, Zhengnan Ming, Xiaodan Chen, Li Xia, Wensong Luo, Jijia Li, Na Xu, Ling Chen, Dongsheng Cao, Min Wen, Fanrong Kong, Kunjian Peng, Yuanzhu Xie, Xuan Li, Dayou Ma, Chuanyu Yang, Ceshi Chen, Wenjun Yi, Ousheng Liu, Suyou Liu
Nature Communications.2021;[Epub]     CrossRef
Arginine Metabolism and Its Potential in Treatment of Colorectal Cancer
Tao Du, Junyi Han
Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
Targeting Immunometabolism in Glioblastoma
Aditya A. Mohan, William H. Tomaszewski, Aden P. Haskell-Mendoza, Kelly M. Hotchkiss, Kirit Singh, Jessica L. Reedy, Peter E. Fecci, John H. Sampson, Mustafa Khasraw
Frontiers in Oncology.2021;[Epub]     CrossRef
Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level
Serena Pillozzi, Andrea Bernini, Ilaria Palchetti, Olivia Crociani, Lorenzo Antonuzzo, Domenico Campanacci, Guido Scoccianti
Cancers.2021; 13(12): 3044.     CrossRef
Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment
Neha Kumari, Saurabh Bansal
Cancer Chemotherapy and Pharmacology.2021; 88(4): 565.     CrossRef
Metabolic Alterations in Preneoplastic Development Revealed by Untargeted Metabolomic Analysis
Henna Myllymäki, Jeanette Astorga Johansson, Estefania Grados Porro, Abigail Elliot, Tessa Moses, Yi Feng
Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
Dysregulated Alanine as a Potential Predictive Marker of Glioma—An Insight from Untargeted HRMAS-NMR and Machine Learning Data
Safia Firdous, Rizwan Abid, Zubair Nawaz, Faisal Bukhari, Ammar Anwer, Leo L. Cheng, Saima Sadaf
Metabolites.2021; 11(8): 507.     CrossRef
Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer
Peter W. Szlosarek, Akhila G. Wimalasingham, Melissa M. Phillips, Peter E. Hall, Pui Ying Chan, John Conibear, Louise Lim, Sukaina Rashid, Jeremy Steele, Paula Wells, Chiung‐Fang Shiu, Chih‐Ling Kuo, Xiaoxing Feng, Amanda Johnston, John Bomalaski, Stephen
Cancer Medicine.2021; 10(19): 6642.     CrossRef
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
Yaolin Xu, Lijie He, Qiang Fu, Junzhe Hu
Frontiers in Oncology.2021;[Epub]     CrossRef
Fueling T-cell Antitumor Immunity: Amino Acid Metabolism Revisited
Chenfeng Han, Minmin Ge, Ping-Chih Ho, Lianjun Zhang
Cancer Immunology Research.2021; 9(12): 1373.     CrossRef
Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
Andreia Matos, Marcos Carvalho, Manuel Bicho, Ricardo Ribeiro
Nutrients.2021; 13(12): 4503.     CrossRef
GC/MS-based differential metabolic profiling of human peptic ulcer disease to study Helicobacter pylori-induced metabolic perturbations
GAGANJOT GUPTA, DEEPAK BANSAL, ANSHULA SHARMA, TAWSEEF AHMAD, ATUL SACHDEV, AJAZ AHMAD, HAMED A. EL-SEREHY, BALJINDER KAUR
BIOCELL.2021; 45(5): 1299.     CrossRef
New aspects of amino acid metabolism in cancer
Lisa Vettore, Rebecca L. Westbrook, Daniel A. Tennant
British Journal of Cancer.2020; 122(2): 150.     CrossRef
Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1
Giulia Agnello, Susan E. Alters, Scott W. Rowlinson
Translational Research.2020; 217: 11.     CrossRef
Tumour metabolism and its unique properties in prostate adenocarcinoma
David A. Bader, Sean E. McGuire
Nature Reviews Urology.2020; 17(4): 214.     CrossRef
Dietary Approaches to Cancer Therapy
Mylène Tajan, Karen H. Vousden
Cancer Cell.2020; 37(6): 767.     CrossRef
Myeloid Cell-Derived Arginase in Cancer Immune Response
Tomasz M. Grzywa, Anna Sosnowska, Paweł Matryba, Zuzanna Rydzynska, Marcin Jasinski, Dominika Nowis, Jakub Golab
Frontiers in Immunology.2020;[Epub]     CrossRef
Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer
Peter E. Hall, Neal Ready, Amanda Johnston, John S. Bomalaski, Ralph R. Venhaus, Michael Sheaff, Lee Krug, Peter W. Szlosarek
Clinical Lung Cancer.2020; 21(6): 527.     CrossRef
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
Caitlyn B. Brashears, Meltem Barlin, William R. Ehrhardt, Richa Rathore, Matthew Schultze, Shin-Chen Tzeng, Brian A. Van Tine, Jason M. Held
Cell Death & Disease.2020;[Epub]     CrossRef
The free amino acid profiles and metabolic biomarkers of predicting the chemotherapeutic response in advanced sarcoma patients
B. Jia, W. Wang, S. Lin, L. Shi, Y. Li, Y. Gu, F. Gao, Y. Qin
Clinical and Translational Oncology.2020; 22(12): 2213.     CrossRef
Exercise May Affect Metabolism in Cancer-Related Cognitive Impairment
Muhammad Shahid, Jayoung Kim
Metabolites.2020; 10(9): 377.     CrossRef
Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
Seema Gupta, Bilikere S. Dwarakanath
Current Medicinal Chemistry.2020; 27(24): 4002.     CrossRef
Combinatory Treatment of Canavanine and Arginine Deprivation Efficiently Targets Human Glioblastoma Cells via Pleiotropic Mechanisms
Olena Karatsai, Pavel Shliaha, Ole N. Jensen, Oleh Stasyk, Maria Jolanta Rędowicz
Cells.2020; 9(10): 2217.     CrossRef
The Janus-like role of proline metabolism in cancer
Lynsey Burke, Inna Guterman, Raquel Palacios Gallego, Robert G. Britton, Daniel Burschowsky, Cristina Tufarelli, Alessandro Rufini
Cell Death Discovery.2020;[Epub]     CrossRef
Development of cancer prognostic signature based on pan-cancer proteomics
Weiguo Huang, Jianhui Chen, Wanqing Weng, Yukai Xiang, Hongqi Shi, Yunfeng Shan
Bioengineered.2020; 11(1): 1368.     CrossRef
Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms
Peter W. Szlosarek, Melissa M. Phillips, Iuliia Pavlyk, Jeremy Steele, Jonathan Shamash, James Spicer, Sanjeev Kumar, Simon Pacey, Xiaoxing Feng, Amanda Johnston, John Bomalaski, Graeme Moir, Kelvin Lau, Stephen Ellis, Michael Sheaff
JTO Clinical and Research Reports.2020; 1(4): 100093.     CrossRef
Selective extracellular arginine deprivation by a single injection of cellular non-uptake arginine deiminase nanocapsules for sustained tumor inhibition
Hongzhao Qi, Yin Wang, Xubo Yuan, Peifeng Li, Lijun Yang
Nanoscale.2020; 12(47): 24030.     CrossRef
Role of amino acid metabolism in angiogenesis
Roxana E. Oberkersch, Massimo M. Santoro
Vascular Pharmacology.2019; 112: 17.     CrossRef
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Nishant Gandhi, Gokul Das
Cells.2019; 8(2): 89.     CrossRef
Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma
Xuemei Tao, Qiaozhu Zuo, Haoyu Ruan, Hui Wang, Haojie Jin, Zhuoan Cheng, Yuanyuan Lv, Wenxin Qin, Cun Wang
Acta Biochimica et Biophysica Sinica.2019; 51(3): 263.     CrossRef
Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion
Yin Cao, WenWen Ding, JingZi Zhang, Qi Gao, HaoXiang Yang, WangSen Cao, ZhongXia Wang, Lei Fang, RongHui Du
Journal of Proteome Research.2019; 18(5): 2032.     CrossRef
Isolation and screening of extracellular anticancer enzymes from halophilic and halotolerant bacteria from different saline environments in Iran
Mahdis Zolfaghar, Mohammad Ali Amoozegar, Khosro Khajeh, Hamid Babavalian, Hamid Tebyanian
Molecular Biology Reports.2019; 46(3): 3275.     CrossRef
Arginine Deiminase: Current Understanding and Applications
Mahboubeh Zarei, Mohammad Reza Rahbar, Mohammad Hossein Morowvat, Navid Nezafat, Manica Negahdaripour, Aydin Berenjian, Younes Ghasemi
Recent Patents on Biotechnology.2019; 13(2): 124.     CrossRef
The Diverse Functions of Non-Essential Amino Acids in Cancer
Bo-Hyun Choi, Jonathan L. Coloff
Cancers.2019; 11(5): 675.     CrossRef
Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Vadim S. Pokrovsky, Olga E. Chepikova, Denis Zh. Davydov, Andrey A. Zamyatnin Jr, Alexander N. Lukashev, Elena V. Lukasheva
Current Medicinal Chemistry.2019; 26(3): 446.     CrossRef
Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer
Lamia Mouhid, Marta Gómez de Cedrón, Elena García-Carrascosa, Guillermo Reglero, Tiziana Fornari, Ana Ramírez de Molina, Olga A. Sukocheva
PLOS ONE.2019; 14(3): e0214294.     CrossRef
Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity
Ashraf S.A. El-Sayed, Ahmed A. Shindia, Azza A. Abou Zeid, Amany M. Yassin, Mahmoud Z. Sitohy, Basel Sitohy
Enzyme and Microbial Technology.2019; 131: 109432.     CrossRef
Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability
Anke Werner, Daniel Pieh, Hakim Echchannaoui, Johanna Rupp, Krishnaraj Rajalingam, Matthias Theobald, Ellen I. Closs, Markus Munder
Frontiers in Oncology.2019;[Epub]     CrossRef
Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
Bethany C. Prudner, Richa Rathore, Anthony M. Robinson, Abigail Godec, Samuel F. Chang, William G. Hawkins, Angela C. Hirbe, Brian A. Van Tine
Clinical Cancer Research.2019; 25(16): 5122.     CrossRef
Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM
Lina Mörén, Richard Perryman, Tim Crook, Julia K. Langer, Kevin Oneill, Nelofer Syed, Henrik Antti
BMC Cancer.2018;[Epub]     CrossRef
Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20
Sounak Gupta, Divya Sahu, John S. Bomalaski, Igor Frank, Stephen A. Boorjian, Prabin Thapa, John C. Cheville, Donna E. Hansel
Endocrine Pathology.2018; 29(3): 236.     CrossRef
Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy
Mozhgan Jahani, Fatemeh Noroznezhad, Kamran Mansouri
Biomedicine & Pharmacotherapy.2018; 102: 594.     CrossRef
Identification of metabolites in plasma for predicting survival in glioblastoma
Jie Shen, Renduo Song, Tiffany R. Hodges, Amy B. Heimberger, Hua Zhao
Molecular Carcinogenesis.2018; 57(8): 1078.     CrossRef
The Citrulline Recycling Pathway Sustains Cardiovascular Function in Arginine-Depleted Healthy Mice, but Cannot Sustain Nitric Oxide Production during Endotoxin Challenge
Yang Yuan, Mahmoud A Mohammad, Ancizar Betancourt, Inka C Didelija, Chandrasekar Yallampalli, Juan C Marini
The Journal of Nutrition.2018; 148(6): 844.     CrossRef
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes
Constantinos Alexandrou, Saif Sattar Al-Aqbi, Jennifer A. Higgins, William Boyle, Ankur Karmokar, Catherine Andreadi, Jin-Li Luo, David A. Moore, Maria Viskaduraki, Matthew Blades, Graeme I. Murray, Lynne M. Howells, Anne Thomas, Karen Brown, Paul N. Chen
Scientific Reports.2018;[Epub]     CrossRef
Metal ions-induced stability and function of bimetallic human arginase-I, a therapeutically important enzyme
Vineet Sadarangani, Safikur Rahman, Apurba Kumar Sau
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2018; 1866(11): 1153.     CrossRef
Rewiring urea cycle metabolism in cancer to support anabolism
Rom Keshet, Peter Szlosarek, Arkaitz Carracedo, Ayelet Erez
Nature Reviews Cancer.2018; 18(10): 634.     CrossRef
TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase
Elena Brin, Katherine Wu, Eleanor Dagostino, Mario Meng-Chiang Kuo, Yudou He, Wei-Jong Shia, Li-Chang Chen, Mariusz Stempniak, Richard Hickey, Robert Almassy, Richard Showalter, James Thomson
Oncotarget.2018; 9(97): 36914.     CrossRef
Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines
Somphon Roeksomtawin, Panida Navasumrit, Somchamai Waraprasit, Varabhorn Parnlob, Thaniya Sricharunrat, Vajarabhongsa Bhudhisawasdi, Niramol Savaraj, Mathuros Ruchirawat
Oncology Letters.2018;[Epub]     CrossRef
Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization
C. Noreen Hinrichs, Mirjam Ingargiola, Theresa Käubler, Steffen Löck, Achim Temme, Alvaro Köhn-Luque, Andreas Deutsch, Olena Vovk, Oleh Stasyk, Leoni A. Kunz-Schughart
Molecular Cancer Therapeutics.2018; 17(2): 393.     CrossRef
Metabolic synthetic lethality in cancer therapy
Vincent Zecchini, Christian Frezza
Biochimica et Biophysica Acta (BBA) - Bioenergetics.2017; 1858(8): 723.     CrossRef
Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase–Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase
Divya Sahu, Sounak Gupta, Andrew M. Hau, Kazufumi Nakashima, Mariah Z. Leivo, Stephen C. Searles, Paul Elson, John S. Bomalaski, Darren E. Casteel, Gerry R. Boss, Donna E. Hansel
The American Journal of Pathology.2017; 187(1): 200.     CrossRef
Construction and in vitro evaluation of enzyme nanoreactors based on carboxymethyl chitosan for arginine deprivation in cancer therapy
Tian Zeng, Yi Zhang, Qiongjiao Yan, Zhijun Huang, Ling Zhang, Xiaozhe Yi, Junrong Chen, Guanghua He, Yihua Yin
Carbohydrate Polymers.2017; 162: 35.     CrossRef
Drug target identification at the crossroad of neuronal apoptosis and survival
Barbara Maino, Simona Paparone, Cinzia Severini, Maria Teresa Ciotti, Velia D’agata, Pietro Calissano, Sebastiano Cavallaro
Expert Opinion on Drug Discovery.2017; 12(3): 249.     CrossRef
Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
Paulo C. Rodriguez, Augusto C. Ochoa, Amir A. Al-Khami
Frontiers in Immunology.2017;[Epub]     CrossRef
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden, Ralph J. DeBerardinis
Cell.2017; 168(4): 657.     CrossRef
Designing Smart Materials with Recombinant Proteins
Sydney Hollingshead, Charng‐Yu Lin, Julie C. Liu
Macromolecular Bioscience.2017;[Epub]     CrossRef
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
Emma Beddowes, James Spicer, Pui Ying Chan, Ramsay Khadeir, Javier Garcia Corbacho, Dimitra Repana, Jeremy P. Steele, Peter Schmid, Teresa Szyszko, Gary Cook, Monica Diaz, Xiaoxing Feng, Amanda Johnston, Jim Thomson, Michael Sheaff, Bor-Wen Wu, John Bomal
Journal of Clinical Oncology.2017; 35(16): 1778.     CrossRef
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Seema Gupta, Amrita Roy, Bilikere S. Dwarakanath
Frontiers in Oncology.2017;[Epub]     CrossRef
The interplay between metabolic remodeling and immune regulation in glioblastoma
Pravin Kesarwani, Shiva Kant, Antony Prabhu, Prakash Chinnaiyan
Neuro-Oncology.2017; 19(10): 1308.     CrossRef
PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction
Mamta Verma, Ramya Chandar M. Charles, Baskar Chakrapani, Mohane Selvaraj Coumar, Gayathri Govindaraju, Arumugam Rajavelu, Sreenivas Chavali, Arunkumar Dhayalan
Journal of Molecular Biology.2017; 429(15): 2278.     CrossRef
Technetium-99m complexes ofl-arginine derivatives for targeting amino acid transporters
Maurício Morais, Vera F. C. Ferreira, Flávio Figueira, Filipa Mendes, Paula Raposinho, Isabel Santos, Bruno L. Oliveira, João D. G. Correia
Dalton Transactions.2017; 46(42): 14537.     CrossRef
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Gabriela Andrejeva, Jeffrey C. Rathmell
Cell Metabolism.2017; 26(1): 49.     CrossRef
Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation
Ho-Joon Lee, Mark P. Jedrychowski, Arunachalam Vinayagam, Ning Wu, Ng Shyh-Chang, Yanhui Hu, Chua Min-Wen, Jodene K. Moore, John M. Asara, Costas A. Lyssiotis, Norbert Perrimon, Steven P. Gygi, Lewis C. Cantley, Marc W. Kirschner
Cell Reports.2017; 20(3): 721.     CrossRef
A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
Maeve A. Lowery, Kenneth H. Yu, David Paul Kelsen, James J. Harding, John S. Bomalaski, Danielle C. Glassman, Christina M. Covington, Robin Brenner, Ellen Hollywood, Adalberto Barba, Amanda Johnston, Kay Chia‐Wei Liu, Xiaoxing Feng, Marinela Capanu, Ghass
Cancer.2017; 123(23): 4556.     CrossRef
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
Hui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, Gautam Borthakur, Sheng-Fung Lin, Naveen Pemmaraju, Elias Jabbour, John S. Bomalaski, Ya-Ping Chen, Hui-Hua Hsiao, Ming-Chung Wang, Ching-Yuan Kuo, Hung Chang, Su-Peng Yeh, Jorge Cortes, Li-Tzong Chen, Tsai-Y
Scientific Reports.2017;[Epub]     CrossRef
Targeting Metabolism for Cancer Therapy
Alba Luengo, Dan Y. Gui, Matthew G. Vander Heiden
Cell Chemical Biology.2017; 24(9): 1161.     CrossRef
Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine
Minoru Tomizawa, Fuminobu Shinozaki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige
Oncology Letters.2017; 13(3): 1264.     CrossRef
PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration
Elena Brin, Katherine Wu, Hsin-Tze Lu, Yudou He, Zhaoming Dai, Wei He
Oncotarget.2017; 8(35): 58948.     CrossRef
Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents
W-B Tsai, Y Long, J-R Park, J T Chang, H Liu, J Rodriguez-Canales, N Savaraj, L G Feun, M A Davies, I I Wistuba, M T Kuo
Oncogene.2016; 35(13): 1632.     CrossRef
Comparative proteome analysis across non-small cell lung cancer cell lines
Kathrin Grundner-Culemann, J. Nikolaj Dybowski, Martin Klammer, Andreas Tebbe, Christoph Schaab, Henrik Daub
Journal of Proteomics.2016; 130: 1.     CrossRef
Arginine deprivation induces endoplasmic reticulum stress in human solid cancer cells
Yaroslav Bobak, Yuliya Kurlishchuk, Bozhena Vynnytska-Myronovska, Olesia Grydzuk, Galyna Shuvayeva, Maria J. Redowicz, Leoni A. Kunz-Schughart, Oleh Stasyk
The International Journal of Biochemistry & Cell Biology.2016; 70: 29.     CrossRef
Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells
Tzyy-Harn Yeh, Yun-Ru Chen, Szu-Ying Chen, Wei-Chiang Shen, David K. Ann, Jennica L. Zaro, Li-Jiuan Shen
Molecular Pharmaceutics.2016; 13(1): 262.     CrossRef
Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy
Lifeng Xiong, Jade Teng, Michael Botelho, Regina Lo, Susanna Lau, Patrick Woo
International Journal of Molecular Sciences.2016; 17(3): 363.     CrossRef
Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug
Rui-Zhi Han, Guo-Chao Xu, Jin-Jun Dong, Ye Ni
Applied Microbiology and Biotechnology.2016; 100(11): 4747.     CrossRef
Arginine dependence of tumor cells: targeting a chink in cancer’s armor
M D Patil, J Bhaumik, S Babykutty, U C Banerjee, D Fukumura
Oncogene.2016; 35(38): 4957.     CrossRef
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?
Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, Francesco Passiglia, Antonio Galvano, Fabio Rizzo, Christian Rolfo, Daniele Fanale, Angela Listì, Clara Natoli, Viviana Bazan, Antonio Russo
Critical Reviews in Oncology/Hematology.2016; 107: 20.     CrossRef
Serine and one-carbon metabolism in cancer
Ming Yang, Karen H. Vousden
Nature Reviews Cancer.2016; 16(10): 650.     CrossRef
Argininosuccinate Synthetase 1 (ASS1) Is a Common Metabolic Marker of Chemosensitivity for Targeted Arginine- and Glutamine-Starvation Therapy
Yan Long, Wen-Bin Tsai, Dajuan Wang, David H. Hawke, Niramol Savaraj, Lynn G. Feun, Mien-Chie Hung, Helen H.W. Chen, Macus Tien Kuo
Cancer Letters.2016;[Epub]     CrossRef
Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR
Hailong Zhang, Liang Qiao, Xiaopeng Li, Yang Wan, Li Yang, Huijuan Wang
Oncology Reports.2016; 36(6): 3436.     CrossRef
Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes
Hua Zhao, Amy B. Heimberger, Zhimin Lu, Xifeng Wu, Tiffany R. Hodges, Renduo Song, Jie Shen
Oncotarget.2016; 7(15): 20486.     CrossRef
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma
Yari Ciribilli, Prashant Singh, Alberto Inga, Jürgen Borlak
Oncotarget.2016; 7(40): 65514.     CrossRef
Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation
Yan Long, Wen-Bin Tsai, Jeffrey T. Chang, Marcos Estecio, Medhi Wangpaichitr, Naramol Savaraj, Lynn G. Feun, Helen H.W. Chen, Macus Tien Kuo
Oncotarget.2016; 7(50): 82658.     CrossRef
Co-application of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability
Yuliya Kurlishchuk, Bozhena Vynnytska-Myronovska, Philipp Grosse-Gehling, Yaroslav Bobak, Friederike Manig, Oleg Chen, Sebastian R. Merker, Thomas Henle, Steffen Löck, Daniel E. Stange, Oleh Stasyk, Leoni A. Kunz-Schughart
Oncotarget.2016; 7(45): 73292.     CrossRef
Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond
Elitsa A Ananieva, Jonathan D Powell, Susan M Hutson
Advances in Nutrition.2016; 7(4): 798S.     CrossRef
Arginine deprivation in cancer therapy
Lynn G. Feun, Macus Tien Kuo, Niramol Savaraj
Current Opinion in Clinical Nutrition and Metabolic Care.2015; 18(1): 78.     CrossRef
Recombinant arginine‐degrading enzymes in metabolic anticancer therapy and bioanalytics
Oleh V. Stasyk, Yuriy R. Boretsky, Mykhailo V. Gonchar, Andriy A. Sibirny
Cell Biology International.2015; 39(3): 246.     CrossRef
Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy
Ann E. Walts, John S. Bomalaski, Delma Ines, Sandra Orsulic
Journal of Cancer Research and Clinical Oncology.2015; 141(8): 1363.     CrossRef
Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
Shih-Chang Shiue, Miao-Zeng Huang, Ting-Fen Tsai, Alice Chien Chang, Kong Bung Choo, Chiu-Jung Huang, Tsung-Sheng Su
Journal of Biomedical Science.2015;[Epub]     CrossRef
Perioperative dynamics and significance of amino acid profiles in patients with cancer
Yu Gu, Tianxiang Chen, Suzhen Fu, Xin Sun, Lingyan Wang, Jian Wang, Yingfeng Lu, Songming Ding, Guodong Ruan, Lisong Teng, Min Wang
Journal of Translational Medicine.2015;[Epub]     CrossRef
Nitric oxide synthase in innate and adaptive immunity: an update
Christian Bogdan
Trends in Immunology.2015; 36(3): 161.     CrossRef
Searching for targets for the systemic therapy of mesothelioma
R.A. Stahel, W. Weder, E. Felley-Bosco, U. Petrausch, A. Curioni-Fontecedro, I. Schmitt-Opitz, S. Peters
Annals of Oncology.2015; 26(8): 1649.     CrossRef
Targeting arginine metabolism pathway to treat arginine-dependent cancers
Fuming Qiu, Jian Huang, Meihua Sui
Cancer Letters.2015; 364(1): 1.     CrossRef
Arginine deprivation by arginine deiminase ofStreptococcus pyogenescontrols primary glioblastoma growthin vitroandin vivo
Tomas Fiedler, Madlen Strauss, Silvio Hering, Ulrike Redanz, Doreen William, Yvonne Rosche, Carl Friedrich Classen, Bernd Kreikemeyer, Michael Linnebacher, Claudia Maletzki
Cancer Biology & Therapy.2015; 16(7): 1047.     CrossRef
Arginine addiction in AML
William Plunkett
Blood.2015; 125(26): 3971.     CrossRef
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo
Farideh Miraki-Moud, Essam Ghazaly, Linda Ariza-McNaughton, Katharine A. Hodby, Andrew Clear, Fernando Anjos-Afonso, Konstantinos Liapis, Marianne Grantham, Fareeda Sohrabi, Jamie Cavenagh, John S. Bomalaski, John G. Gribben, Peter W. Szlosarek, Dominique
Blood.2015; 125(26): 4060.     CrossRef
Therapeutic interventions to disrupt the protein synthetic machinery in melanoma
Gregory R. Kardos, Gavin P. Robertson
Pigment Cell & Melanoma Research.2015; 28(5): 501.     CrossRef
Research into cancer metabolomics: Towards a clinical metamorphosis
Orianne Olivares, J. Henry M. Däbritz, Ayala King, Eyal Gottlieb, Christina Halsey
Seminars in Cell & Developmental Biology.2015; 43: 52.     CrossRef
Argininosuccinate lyase is a potential therapeutic target in breast cancer
HAU-LUN HUANG, WEI-CHING CHEN, HUI-PING HSU, CHIEN-YU CHO, YU-HSUAN HUNG, CHIH-YANG WANG, MING-DERG LAI
Oncology Reports.2015; 34(6): 3131.     CrossRef
Arginine Depletion by Arginine Deiminase Does Not Affect Whole Protein Metabolism or Muscle Fractional Protein Synthesis Rate in Mice
Juan C. Marini, Inka Cajo Didelija, Zane Andrews
PLOS ONE.2015; 10(3): e0119801.     CrossRef
Targeting amino acid metabolism in cancer growth and anti-tumor immune response
Elitsa Ananieva
World Journal of Biological Chemistry.2015; 6(4): 281.     CrossRef
Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14
Alison N. McCracken, Aimee L. Edinger
Biochemical Journal.2015; 470(3): e17.     CrossRef
l-Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
Matthew Fletcher, Maria E. Ramirez, Rosa A. Sierra, Patrick Raber, Paul Thevenot, Amir A. Al-Khami, Dulfary Sanchez-Pino, Claudia Hernandez, Dorota D. Wyczechowska, Augusto C. Ochoa, Paulo C. Rodriguez
Cancer Research.2015; 75(2): 275.     CrossRef
A transgenic approach to study argininosuccinate synthetase gene expression
Shih-Chang Shiue, Miao-Zeng Huang, Tsung-Sheng Su
Journal of Biomedical Science.2014;[Epub]     CrossRef
The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials
Anna Synakiewicz, Teresa Stachowicz-Stencel, Elzbieta Adamkiewicz-Drozynska
Expert Opinion on Investigational Drugs.2014; 23(11): 1517.     CrossRef
Arginine deprivation and autophagic cell death in cancer
Peter Wojciech Szlosarek
Proceedings of the National Academy of Sciences.2014; 111(39): 14015.     CrossRef
Cellular Serpents and Dreaming Spires: New Frontiers in Arginine and Pyrimidine Biology
Gabriel N. Aughey, Ömür Y. Tastan, Ji-Long Liu
Journal of Genetics and Genomics.2014; 41(10): 561.     CrossRef
Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer
Rouzbeh Daylami, Diego J Muilenburg, Subbulakshmi Virudachalam, Richard J Bold
Journal of Experimental & Clinical Cancer Research.2014;[Epub]     CrossRef
Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
Jennifer A McAlpine, Hsin-Tze Lu, Katherine C Wu, Susan K Knowles, James A Thomson
BMC Cancer.2014;[Epub]     CrossRef